Cargando…
Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19
To date, more than 35 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent of coronavirus disease 2019 (COVID-19), and more than one million have died in the COVID-19 pandemic. International economies are stalled and social isolatio...
Autores principales: | Stricker, Raphael B, Fesler, Melissa C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586021/ https://www.ncbi.nlm.nih.gov/pubmed/33116688 http://dx.doi.org/10.2147/IDR.S264831 |
Ejemplares similares
-
Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women
por: Fesler, Melissa C, et al.
Publicado: (2021) -
Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis
por: Stricker, Raphael B., et al.
Publicado: (2021) -
Pre-Exposure Prophylaxis for HIV Infection as a Public Health Tool
por: Beyrer, Chris, et al.
Publicado: (2022) -
Flattening the curve is flattening the complexity of covid-19
por: Boumans, Marcel
Publicado: (2021) -
Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach
por: Seidman, Dominika L, et al.
Publicado: (2017)